UBS Group AG - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 55 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q4 2022$29,701
+98.0%
2,892
+92.8%
0.00%
Q3 2022$15,000
+150.0%
1,500
+150.0%
0.00%
Q2 2022$6,0006000.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q2 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders